International Journal of Molecular Sciences· 2026Q1
Acute Postprandial Glycemic and Antioxidant Responses to Maqui Berry Gummies in Adults with Overweight/Obesity: A Small Within-Subject Pilot Study
- 0citations
- Q1SCImago
- 2026year
Short summary
Consuming maqui berry gummies with white bread lowered post-meal glucose concentrations and increased insulin levels by 120 minutes in adults with overweight/obesity, with microencapsulated gummies showing a greater reduction in total glucose area under the curve.
AI-generated from the title and abstract; the full text is not read.
Key points
- Co-consumption of maqui berry gummies with white bread lowered postprandial glucose concentrations (p < 0.05).
- Microencapsulated maqui berry gummies (MMBG) resulted in a lower total glucose area under the curve compared to control (p < 0.0207).
- Insulin levels at 120 minutes were higher with both gummy formulations (p < 0.01).
- GLP-1 levels were higher with MMBG (p < 0.05), though changes from baseline were not significant.
- Antioxidant markers showed differential responses between unencapsulated and microencapsulated gummies.
AI-generated from the title and abstract; the full text is not read.
Abstract
Maqui berry is rich in anthocyanins and has attracted interest as a functional food ingredient with potential metabolic and antioxidant effects. However, little is known about its acute postprandial effects in gummy formulations or whether microencapsulation modifies sensory or biological responses. Ten adults with overweight or obesity completed three acute conditions in a fixed sequence: white bread alone (Control), white bread with unencapsulated maqui berry gummies (UMBG), and white bread with microencapsulated maqui berry gummies (MMBG). Glucose was assessed over 120 min; insulin, glucagon-like peptide-1 (GLP-1), superoxide dismutase (SOD), catalase, and total reactive antioxidant power (TRAP) were assessed at baseline and 120 min. Sensory acceptability was evaluated separately in 66 panelists. Both formulations showed generally acceptable sensory profiles. In the reported analyses, co-consumption of gummies was associated with lower glucose concentrations (p < 0.05), and total glucose AUC was lower under MMBG than under Control (p < 0.0207). Insulin at 120 min was higher under both gummy conditions (p < 0.01), and GLP-1 was higher under MMBG (p < 0.05); however, changes in GLP-1 from baseline did not differ significantly among conditions (p > 0.05). Direct comparisons of baseline-adjusted analyses in antioxidant biomarkers established a differential response among gummies formulations, with UMBG exhibiting better TRAP results with decrement of SOD activity when adjusted for the corresponding baseline value. These preliminary observations warrant further investigation. The small sample, fixed intervention sequence, and absence of a matched placebo gummy limit causal attribution. The reported findings do not establish antioxidant protection or superiority of microencapsulation and require confirmation in an adequately powered randomized trial.
The authors' abstract, as published at the source. International Journal of Molecular Sciences, 2026 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Biochemistry (Medicine)
BiochemistryMedicine